Senior Investment Analyst
Phil is a senior investment analyst on the firm’s investment team. Prior to joining GQG Partners, he spent six years at Senzar Asset Management where he was a senior research analyst. Phil spent 12 years doing drug discovery and development within the pharmaceutical industry with the bulk of that time being spent at Merck. After his industrial career, he spent one year as a program officer at the National Institutes of Health and moved to academia where he was a Professor of Molecular Therapeutics and Neuroscience at The Scripps Research Institute for 11 years. Phil did postdoctoral training in cardiovascular disease at the Sandoz Research Institute after receiving a PhD in Pharmacology from the University of Florida, an MS in Biochemistry from Florida State University, and a BA in Chemistry from New York University.